Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Women With HER2-positive Early Breast Cancer

NCT01901146 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

725

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: ABP 980
DRUG: Trastuzumab
DRUG: Paclitaxel
PROCEDURE: Lumpectomy or Mastectomy with Sentinel Node or Axillary Node Dissection

Sponsor

Amgen

Collaborators

[object Object]